Dexcom (DXCM) Long-Term Deferred Tax (2020 - 2026)
Dexcom has reported Long-Term Deferred Tax over the past 7 years, most recently at $296.1 million for Q1 2026.
- Quarterly Long-Term Deferred Tax fell 39.24% to $296.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $296.1 million through Mar 2026, down 39.24% year-over-year, with the annual reading at $295.6 million for FY2025, 38.57% down from the prior year.
- Long-Term Deferred Tax was $296.1 million for Q1 2026 at Dexcom, roughly flat from $295.6 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $501.3 million in Q3 2023 and troughed at $290.8 million in Q1 2022.
- The 5-year median for Long-Term Deferred Tax is $417.0 million (2023), against an average of $401.5 million.
- Year-over-year, Long-Term Deferred Tax skyrocketed 58.25% in 2022 and then crashed 39.24% in 2026.
- A 5-year view of Long-Term Deferred Tax shows it stood at $341.2 million in 2022, then grew by 22.92% to $419.4 million in 2023, then rose by 14.74% to $481.2 million in 2024, then crashed by 38.57% to $295.6 million in 2025, then grew by 0.17% to $296.1 million in 2026.
- Per Business Quant, the three most recent readings for DXCM's Long-Term Deferred Tax are $296.1 million (Q1 2026), $295.6 million (Q4 2025), and $375.6 million (Q3 2025).